Libraries

• Library Home
• Find Books and More (Catalog)
• Find Articles and Databases
• EReserves
• Student Services
• Faculty Services
• Newsletter

Search

Publications for William Dager

• Dager, W. E. (2010). Issues in assessing and reducing the risk for venous thromboembolism. American Journal of Health-System Pharmacy, 67(10 Suppl. 6), S9-16. doi: 10.2146/ajhp100177 This material can be found here.

• Dager, W. E., & Kiser, T. H. (2010). Systemic anticoagulation considerations in chronic kidney disease. Advances in Chronic Kidney Disease, 17(5), 420-427. doi: 10.1053/j.ackd.2010.06.002 This material can be found here.

• Dager, W. E., Gulseth, M. P., & Nutescu, E. A. (2010). Anticoagulation therapy: A point of care guide. Bethesda, MD: American Society of Health-System Pharmacists.

• Dager, W. E., Shulman, R., & Jacobi, J. (2010). Preparation and training of critical care pharmacists. In H. Flaatten, R. P. Moreno, C. Putensen, & A. Rhodes, (Eds.), Organisation and management of intensive care (pp. 133-142). Berlin, Germany: Medical Scientific Publishing GmbH & Co. This material can be found here.

• Haines, S. T., Dager, W. E., & Trujillo, T. C. (2010). Clinical and management challenges in preventing venous thromboembolism in health systems: A case-based panel discussion. American Journal of Health-System Pharmacy, 67(10 Suppl. 6), S26-S30. doi: 10.2146/ajhp100179 This material can be found here.

• Matzke, G. R., Dager, W. E., & Heintz, B. H. (2010). Dialysis of drugs. In K. M. Smith, D. M. Riche, & N. N. Henyan (Eds.), Clinical drug data (11th ed., pp. 1132-1140). New York, NY: McGraw-Hill.

• Matzke, G. R., Dager, W. E., & Heintz, B. H. (2010). Renal disease. In K. M. Smith, D. M. Riche, & N. N. Henyan (Eds.), Clinical drug data (11th ed., pp. 1123-1131). New York, NY: McGraw-Hill.

• Nishijima, D. K., Dager, W. E., Schrot, R. J., & Holmes, J. F. (2010). The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage. Academic Emergency Medicine, 17(3), 244-251. doi: 10.1111/j.1553-2712.2010.00666.x This material can be found here.

• Prinzola, J. L., Smythe, M. A., & Dager, W. E. (2010). Drug-induced thrombocytopenias in the critically ill. Critical Care Medicine, 38(Suppl. 6), S145-S154. doi: 10.1097/CCM.0b013e3181de0b88 This material can be found here.

• Wittkowsky, A., Spinler, S., Dager, W. E., Gulseth, M., & Nutescu, M. (2010). Dosing guidelines, not protocols, for managing warfarin therapy. American Journal of Health-System Pharmacy, 67(18), 1554-1556. This material can be found here.

• Dager, W. E. (2009). Dosing nomograms: Silos on a slope [editorial]. Annals of Pharmacotherapy, 43(1), 114-117. This material can be found here.

• Dobesh, P. P., Wittkowsky, A. K., Stacy, Z., Dager, W. E., Haines, S. T., Lopez, L. M.,...Vondracek, T. (2009). Key articles and guidelines for the prevention of venous thromboembolism. Pharmacotherapy, 29(4), 410-458. This material can be found here.

• Erstad, B. L., Brophy, G. M., Martin, S. J., Haas, C. E., Devlin, J. W., Welage, L. S., & Dager, W. E. (2009). Key articles and guidelines relative to intensive care unit pharmacology: 2009 update. Pharmacotherapy, 29(10), 1228-1269. This material can be found here.

• Gulseth, M., Grice, G., & Dager, W. E. (2009). Pharmacogenomics of Warfarin: Uncovering a piece of the Warfarin mystery. American Journal of Health-System Pharmacy, 66(2), 123-133.

• Heintz, B. H., Matzke, G. R., & Dager, W. E. (2009). Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy, 29(5), 562-577. This material can be found here.

• Nutescu, E. A., Spinler, S. A., Wittkowsky, A., & Dager, W. E. (2009). Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Annals of Pharmacotherapy, 43(6), 1064-1083. This material can be found here.